Your browser doesn't support javascript.
loading
Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.
Jerome, Rebecca N; Pulley, Jill M; Roden, Dan M; Shirey-Rice, Jana K; Bastarache, Lisa A; R Bernard, Gordon; B Ekstrom, Leeland; Lancaster, William J; Denny, Joshua C.
Afiliación
  • Jerome RN; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA. rebecca.jerome@vumc.org.
  • Pulley JM; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Roden DM; Office of Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shirey-Rice JK; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Bastarache LA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • R Bernard G; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • B Ekstrom L; Office of Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Lancaster WJ; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Denny JC; Nashville Biosciences, Nashville, TN, USA.
Drug Saf ; 41(3): 303-311, 2018 03.
Article en En | MEDLINE | ID: mdl-29185237
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Disrafia Espinal / Inhibidores Enzimáticos / Inhibidores de PCSK9 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Drug Saf Asunto de la revista: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Disrafia Espinal / Inhibidores Enzimáticos / Inhibidores de PCSK9 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Drug Saf Asunto de la revista: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos